Michaela Wendeler

Title: Michaela Wendeler: Innovator in Immunoconjugates and Coagulation Factors

Introduction

Michaela Wendeler is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the fields of immunoconjugates and coagulation factors. With a total of 2 patents, her work has advanced the understanding and application of these important biomedical technologies.

Latest Patents

Michaela's latest patents include innovative methods for producing immunoconjugates. The first patent focuses on methods of preparing active immunoconjugates, including anti-CD22 immunoconjugates. These methods utilize a fed-batch refolding process and/or column stripping process, resulting in an increased yield of the immunoconjugate compared to other processes. The second patent relates to methods for processing coagulation factors, specifically for purifying recombinant coagulation factor proteins such as prothrombin (Factor II). This method provides purified prothrombin that exhibits increased bioactivity and reduced levels of thrombin, thereby enhancing the safety of the prothrombin.

Career Highlights

Michaela Wendeler is currently associated with MedImmune Limited, where she continues to innovate in her field. Her work has garnered attention for its potential impact on therapeutic applications and patient safety.

Collaborations

Michaela has collaborated with notable colleagues, including Timothy Pabst and Alan Hunter. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Michaela Wendeler is a distinguished inventor whose work in immunoconjugates and coagulation factors has made a significant impact in the biomedical field. Her innovative methods and collaborations highlight her commitment to advancing medical science.